Amyloidosis explained

By SWA

Amyloidosis is a rare and complex group of diseases characterized by the abnormal accumulation of amyloid protein in various organs and tissues of the body. Amyloid is an insoluble, fibrous protein that can build up in different parts of the body, disrupting normal tissue structure and function. There are several types of amyloidosis, each associated with different proteins and organ systems affected.

Here are some key points about amyloidosis:

  1. Types of Amyloidosis: There are several types of amyloidosis, but the most common ones include:

    • AL Amyloidosis (Immunoglobulin Light Chain Amyloidosis): This type is associated with the accumulation of abnormal immunoglobulin light chain proteins, often produced by abnormal plasma cells in the bone marrow. It can affect various organs, including the heart, kidneys, nervous system, and digestive tract.

    • AA Amyloidosis (Amyloid A Protein Amyloidosis): This type is linked to the buildup of amyloid A protein, which is usually a response to chronic inflammatory or infectious diseases, such as rheumatoid arthritis or tuberculosis. AA amyloidosis typically affects the kidneys, liver, and spleen.

    • ATTR Amyloidosis (Transthyretin Amyloidosis): This type is caused by the accumulation of transthyretin protein, primarily in the heart and peripheral nerves. ATTR amyloidosis can be hereditary (caused by mutations in the TTR gene) or acquired (associated with aging).

  2. Symptoms: The symptoms of amyloidosis can vary widely depending on the affected organs and the type of amyloidosis. Common symptoms may include fatigue, weight loss, swelling, shortness of breath, heart palpitations, kidney problems, neuropathy (nerve damage), gastrointestinal issues, and skin changes.

  3. Diagnosis: Diagnosis of amyloidosis can be challenging and often requires a combination of tests, including blood and urine tests, tissue biopsies (usually from the affected organ), and imaging studies like echocardiograms or MRI scans. Identifying the specific type of amyloidosis is crucial for determining the appropriate treatment approach.

  4. Treatment: The treatment of amyloidosis depends on the type and extent of organ involvement. Options may include chemotherapy, stem cell transplantation (for AL amyloidosis), medications to stabilize or reduce the production of abnormal proteins, and supportive care to manage symptoms and complications. In some cases, organ transplantation may be considered.

  5. Prognosis: The prognosis for amyloidosis varies depending on the type and stage of the disease, as well as how well it responds to treatment. Some forms of amyloidosis can be life-threatening, particularly when vital organs like the heart or kidneys are severely affected. Early diagnosis and appropriate treatment can significantly improve outcomes.

Amyloidosis is a complex condition that requires specialized medical care. Patients with suspected amyloidosis should seek evaluation and treatment from medical professionals with expertise in the field, such as hematologists, nephrologists, or cardiologists, depending on the affected organs.


Comments

Post a Comment

Popular posts from this blog

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By SWA
Could a virus be the stimulus for cytokine production?   It is well established, but rarely  tested, that a cytokine storm is an overactive immune response characterized by the excessive release of pro-inflammatory cytokines. ( ANA, CRP, and CBC tests are necessary) It can occur in various conditions, such as severe infections (e.g., COVID-19), (and other viruses), autoimmune diseases, and after certain treatments.  Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS-CoV-2 infection: A case report and literature review These cells are called NKG2D+CD8+ T cells and researchers say their aggressive response is responsible for neurological damage suffered from infections beyond just Zika, like COVID-19 and even septic shock. The aggressive response is the result of the body producing large amounts of inflammatory proteins called cytokines, which in moderation help to coordinate the body’s response in battling an infection...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more